TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israël)
LAVA ENERGY LTD (Israël)
Inventeur(s)
Neumann, Yuval
Cassell, Joseph
Rotschild, Carmel
Abrégé
The present disclosure provides a configuration of a system that includes a turbine with impeller section and a nozzle section peripheral and downstream the impeller section. The turbine is a two-phase reaction turbine that employs an isothermal expansion process within its nozzle section. Heat transfer liquid (HTL) and working fluid (WF) are mixed prior to entering the nozzle. The mixture of the HTL and the WF starts at a high pressure Pl at the inlet of the nozzle and ends at a low pressure PO at the outlet of the nozzle, therefore the WF expands within the nozzle and provides kinetic energy to the HTL and therefore to the mixture that causes the acceleration of the mixture towards the outlet of the nozzle. Since all the process is carried out on a rotating turbine, the mixture may tend to be pushed to the walls of the nozzle by the rotational forces as a result of non-symmetrical forces applied on the mixture, which can affect the efficiency of the energy production by the turbine. In order to eliminate such non-symmetrical forces, the nozzle is designed with a curved shape such that the center of mass of the mixture that flows in the nozzle flows at a straight line from a frame the perspective of the inertial system. Namely, the curvature profile of the nozzle is determined according to the intended RPM operation of the turbine. In other words, the nozzle is designed such that the forces acting on the mixture flow in the nozzle causing its center of mass to flow along a flow path that is in the center of the nozzle, at a given operational rotational velocity.
F01K 11/04 - Ensembles fonctionnels de machines à vapeur caractérisés par des machines motrices faisant corps avec les chaudières ou les condenseurs les chaudières ou les condenseurs tournant pendant le fonctionnement
F01K 21/02 - Ensembles fonctionnels de machines motrices à vapeur non prévus ailleurs avec production de vapeur dans les cylindres des machines motrices
F01D 5/04 - Organes de support des aubes, p. ex. rotors pour "machines" ou machines à flux radial
F01K 25/06 - Ensembles fonctionnels ou machines motrices caractérisés par l'emploi de fluides énergétiques particuliers non prévus ailleursEnsembles fonctionnant selon un cycle fermé, non prévus ailleurs utilisant un mélange de fluides différents
2.
UBIQUITIN HIGH AFFINITY CYCLIC PEPTIDES AND METHODS OF USE THEREOF
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israël)
THE UNIVERSITY OF TOKYO (Japon)
Inventeur(s)
Brik, Ashraf
Kamnesky, Guy
Suga, Hiroaki
Huang, Yichao
Rogers, Joseph
Abrégé
The present invention provides cyclic peptides, as well as methods of using the same, such as for ameliorating or treating a K63Ub-related disease in a subject in need thereof.
Technion Research & Development Foundation Limited (Israël)
Inventeur(s)
Attias, Noam
Grobman, Jacob
Abitbol, Tiffany
Abrégé
A method of preparing a composition comprising mycelium along with a cellulose and/or plurality of nanoparticles is described herein. The method comprises inoculating a liquid medium with fungus, the liquid medium comprising nutrients and the cellulose and/or nanoparticles. Further described herein are compositions comprising mycelium along with a cellulose and/or plurality of nanoparticles, as well as articles-of-manufacture comprising such a composition, wherein at least 10% of the cellulose and/or nanoparticles in the composition is incorporated within the mycelium. A method of enhancing fungal growth is also described, comprising contacting the fungus with a liquid medium comprising a polymer which comprises carboxylic acid groups.
Technion Research & Development Foundation Limited (Israël)
MEDICAL RESEARCH & DEVELOPMENT FUND FOR HEALTH SERVICES, BNAI-ZION MEDICAL CENTER (Israël)
Inventeur(s)
Freiman, Mordechay Pinchas
Hanania, Eyal
Cohen, Israe
Abrégé
A method for quantitative magnetic resonance imaging (MRI), the method includes (a) receiving a sequence of MRI images of an in vivo tissue, by an image registration deep neural network (DNN) module that was trained, by a training process, to impose one or more MRI signal related physical constraints on a content of the sequence of MRI images; and (b) extracting one or more quantitative map from the sequence of MRI images.
B. G. NEGEV TECHNOLOGIES AND APPLICATIONS LTD. (Israël)
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israël)
Inventeur(s)
Nir, Oded
Chaudhary, Mohit
Lahav, Ori
Nativ, Paz
Abrégé
This invention relates to a device comprising polyethylene sulfone (PES) and additional suitable polymers with high load of Prussian blue analogue nanoparticles for removal of monovalent or divalent cation contaminants, optionally doped, and process for the preparation and methods for use thereof. The device and method relate to selectively and effectively remove ammoniacal nitrogen removal and recovery as a valuable resource, and removing radioactive cesium and/or other monovalent or divalent cations from contaminated water.
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israël)
Inventeur(s)
Bercovici, Moran
Elgarisi, Mor
Frumkin, Valeri
Luria, Omer
Abrégé
A system and a method of fabricating an article are disclosed. The method comprises: providing an immersion liquid to at least one first portion and at least one second portion of a chamber divided by a divider; opening a valve between the at least one first and at least one second portions; providing a curable liquid to an article frame included in the divider; closing the valve; adjusting a volume or pressure of the immersion liquid in the at least one first portion using a pump, to control a curvature of the article; and curing the curable liquid to form the article.
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israël)
Inventeur(s)
Schroeder, Avraham
Abel, Ravit
Abrégé
The present invention is directed to compositions comprising the Ag2S quantum dots of the invention and to methods for use thereof, such as for the treatment and/or prevention a cell or tissue damage and/or a disease or condition in a subject associated therewith. Further, pharmaceutical or cosmetic compositions comprising Ag2S quantum dots of the invention, and articles (e.g. cosmetic/medical article) comprising same are also provided.
B82Y 15/00 - Nanotechnologie pour l’interaction, la détection ou l'actionnement, p. ex. points quantiques comme marqueurs en dosages protéiques ou moteurs moléculaires
A61P 17/02 - Médicaments pour le traitement des troubles dermatologiques pour traiter les blessures, les ulcères, les brûlures, les cicatrices, les cheloïdes, ou similaires
9.
METHOD DEVICE AND SYSTEM FOR MONITORING SUB-CLINCAL PROGRESSION AND REGRESSION OF HEART FAILURE
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LTD. (Israël)
RAMBAM HEALTH CORPORATION (Israël)
Inventeur(s)
Landesberg, Amir
Tsibulsky, Yakov
Rispler, Shmuel
Abrégé
A method including sensing local accelerations or changes in sensor position, including orientation and displacement, with a local acceleration sensor mounted on a chest or abdomen of a patient, and calculating energy of polyphasic motions, based on sensed information of the local acceleration sensor and classifying severity of cardiac decompensation by calculating an excessive energy index (EEi) that compares excessive energy that appears in the polyphasic motions to energy required for inspiration at a basic respiratory rate.
G16H 50/30 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le calcul des indices de santéTIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour l’évaluation des risques pour la santé d’une personne
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
A61B 5/08 - Dispositifs de mesure pour examiner les organes respiratoires
A61B 5/11 - Mesure du mouvement du corps entier ou de parties de celui-ci, p. ex. tremblement de la tête ou des mains ou mobilité d'un membre
A61B 5/113 - Mesure du mouvement du corps entier ou de parties de celui-ci, p. ex. tremblement de la tête ou des mains ou mobilité d'un membre se produisant au cours de la respiration
G16H 10/60 - TIC spécialement adaptées au maniement ou au traitement des données médicales ou de soins de santé relatives aux patients pour des données spécifiques de patients, p. ex. pour des dossiers électroniques de patients
G16H 40/63 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement local
G16H 50/20 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le diagnostic assisté par ordinateur, p. ex. basé sur des systèmes experts médicaux
10.
SYSTEM OF PROTEIN-PROTEIN INTERACTION AND METHODS OF USING SAME
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israël)
Inventeur(s)
Daniel, Ramez
Samuel, Roee
Habib, Mouna
Abrégé
The present invention provides a system for direct protein-protein interaction between a first cell and a second cell, including: (a) a first cell including a first polynucleotide sequence encoding a first synthetic polypeptide being a membrane anchored ligand including an extracellular portion being a ligand domain and a first membrane anchoring domain; and (b) a second cell including: (i) a second polynucleotide sequence encoding a second synthetic polypeptide being a receptor including an extracellular portion being a binding domain having specific binding affinity to the ligand of (a), a second membrane anchoring domain, and an intracellular portion including a transcription factor; and (ii) a third polynucleotide sequence encoding a gene of interest. Further provided are methods of using the system, and a kit for preparing same.
C12N 15/63 - Introduction de matériel génétique étranger utilisant des vecteursVecteurs Utilisation d'hôtes pour ceux-ciRégulation de l'expression
C12N 15/70 - Vecteurs ou systèmes d'expression spécialement adaptés à E. coli
A61K 48/00 - Préparations médicinales contenant du matériel génétique qui est introduit dans des cellules du corps vivant pour traiter des maladies génétiquesThérapie génique
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israël)
Inventeur(s)
Sacks, Rafael
Wang, Zijian
Ouyang, Boyuan
Abrégé
The present invention relates generally to the technological field of computer-aided design and modeling. In the general aspect, the invention may be directed to a method of federated computer-aided modeling of an object, by at least one processor, the method including: obtaining a plurality of sub-models, complementary representing the object, wherein each sub-model consists of one or more structural elements defined by parameters thereof; for each sub-model, generating a sub-graph representation, having said structural elements and parameters thereof represented as semantic triples; analyzing said semantic triples taken from different sub-graph representations to detect interrelations therebetween; instantiating semantic connections between the generated sub-graph representations, based on detected interrelations, thereby obtaining a meta-graph representation of a model of the object; and developing the model of the object, based on the obtained meta-graph representation.
G06F 30/13 - Conception architecturale, p. ex. conception architecturale assistée par ordinateur [CAAO] relative à la conception de bâtiments, de ponts, de paysages, d’usines ou de routes
G06F 30/27 - Optimisation, vérification ou simulation de l’objet conçu utilisant l’apprentissage automatique, p. ex. l’intelligence artificielle, les réseaux neuronaux, les machines à support de vecteur [MSV] ou l’apprentissage d’un modèle
12.
REEXPRESSION OF HNF4A TO ALLEVIATE CANCER-ASSOCIATED CACHEXIA
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israël)
Inventeur(s)
Erez, Ayelet
Goldman, Omer
Hajaj, Emma
Schroeder, Avi
Abrégé
Methods of predicting clinical outcome in a subject suffering from cancer, detecting non-liver cancer in a subject, and methods of treating or preventing cancer or cancer-associated cachexia are provided. Synthetic lipid nanoparticles encapsulating an mRNA encoding for HNF4A and composition comprising same are also provided.
A61K 48/00 - Préparations médicinales contenant du matériel génétique qui est introduit dans des cellules du corps vivant pour traiter des maladies génétiquesThérapie génique
A61K 38/17 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'animauxPeptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'humains
C07K 16/24 - Immunoglobulines, p. ex. anticorps monoclonaux ou polyclonaux contre du matériel provenant d'animaux ou d'humains contre des cytokines, des lymphokines ou des interférons
13.
MECHANOPHORIC MATRICES AND METHODS OF PREPARING SAME
Technion Research & Development Foundation Limited (Israël)
Inventeur(s)
Grolman, Joshua M.
Liao, Yifan
Zhang, Hang
Diesendruck, Charles Eliezer
Abrégé
Mechanophoric compounds featuring one or more, or two or more, clickable group(s), which are capable of being coupled to naturally occurring, synthetic and/or metallic substrates via Click chemistry, method of preparing mechanophoric matrices using the mechanophoric compounds, and mechanophoric matrices obtainable thereby, and uses thereof for detecting force-induced damage in the matrices by a colorimetric change are provided.
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israël)
Inventeur(s)
Amit, Roee
Vaknin, Inbal
Abrégé
Nucleic acid molecules configured to constitutively express a sequence of interest in a eukaryotic cell comprising a transcription factor binding region, a core promoter and a sequence of interest operatively linked to the transcription factor binding region and core promoter are provided. Methods of constitutively expressing a sequence of interest in a eukaryotic cell are also provided.
Technion Research & Development Foundation Limited (Israël)
Inventeur(s)
Balanov, Amnon
Kaminer, Ido
Abrégé
An X-ray generator is presented comprising: an electron source generating an accelerated electron beam propagating along a first propagation path with a first general propagation direction; a first crystalline structure located in the first propagation path, and defining a first crystal plane oriented at a predetermined non-zero angle with the first propagation path, and configured to transmit the electron beam therethrough and generate parametric x-ray (PXR) emission being first directional emission along a second propagation path tilted with respect to the first general propagation direction; and a second crystalline structure located in the second propagation path and configured as a monochromator with respect to the PXR emission, and defining a second crystal plane oriented at the predetermined non-zero angle with respect to the second propagation path to thereby provide second directionality for the PXR emission.
H05G 2/00 - Appareils ou procédés spécialement adaptés à la production de rayons X, n'utilisant pas de tubes à rayons X, p. ex. utilisant la génération d'un plasma
16.
ECHOCARDIOGRAPHIC METHODS FOR EARLY DETECTION OF CARDIOVASCULAR DETERIORATION, TREATMENT OPTIMIZATION AND SCREENING
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israël)
Inventeur(s)
Landesberg, Amir
Maiorov, Ida
Abrégé
The present invention relates to a method and system for monitoring cardiac functions and quantifying objective, operator-independent indices of cardiac functions. The invention quantifies both ventricle cavity and wall dynamics. It provides a picture with a comprehensive view of the six phases of cardiac contraction, relaxation and filling (isovolumic contraction, ejection, isovolumic relaxation, rapid filling, diastasis and atrial kick). It enables to quantify the effect of respiration and mechanical ventilation on cardiac chamber loadings and thereby to optimize mechanical ventilation in the general and cardiac intensive care units. It enables to assess the phase differences between the electrical activations and mechanical contractions of the various chambers and thus to adjust and optimize the parameters of cardiac synchronization therapies of ventricle chambers and chamber walls (as cardiac resynchronization therapy).
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israël)
Inventeur(s)
Khamaysi, Iyad
Hadad, Salim
Abassi, Zaid
Abrégé
The invention relates generally to the field of compositions including one or more conjugates of di-sugar and a nonsteroidal anti-inflammatory drug (NSAID), and use of same in methods for treating a disease or a disorder in a subject in need thereof.
A61K 31/405 - Acides indole-alkanecarboxyliquesLeurs dérivés, p. ex. tryptophane, indométhacine
A61K 31/194 - Acides carboxyliques, p. ex. acide valproïque ayant plusieurs groupes carboxyle, p. ex. acides succinique, maléique ou phtalique
A61K 31/196 - Acides carboxyliques, p. ex. acide valproïque ayant un groupe amino le groupe amino étant lié directement à un cycle, p. ex. acide anthranilique, acide méfénamique, diclofénac, chlorambucil
A61K 47/54 - Préparations médicinales caractérisées par les ingrédients non actifs utilisés, p. ex. les supports ou les additifs inertesAgents de ciblage ou de modification chimiquement liés à l’ingrédient actif l’ingrédient non actif étant chimiquement lié à l’ingrédient actif, p. ex. conjugués polymère-médicament l’ingrédient non actif étant un agent de modification l’agent de modification étant un composé organique
A61P 13/12 - Médicaments pour le traitement des troubles du système urinaire des reins
18.
SYSTEMS AND METHODS FOR IDENTIFICATION OF IONS IN SOLUTION
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israël)
Inventeur(s)
Manor, Ofer
Aremanda, Sudeepthi
Abrégé
The present invention relates to systems for identifying one or more ions in a liquid solution, including a solid surface configured to be in contact with the liquid solution; a mechanical wave generator configured to be in contact with the solid surface and/or with the liquid solution; and a working microelectrode configured to be positioned in the liquid solution in close proximity to the solid surface without contacting it. Methods of the invention include generating a mechanical wave which propagates and excites ions of an electrical double layer (EDL) formed at an interface between the solid surface and the liquid solution, thereby causing the EDL to vibrate and to leak an electrical field. The electrode measures electrical potential of the electrical field over time, which yields a voltage spectrum comprising amplitude and phase which are indicative of an identity and a concentration of the one or more ions in the liquid solution.
G01N 29/024 - Analyse de fluides en mesurant la vitesse de propagation ou le temps de propagation des ondes acoustiques
G01N 29/22 - Recherche ou analyse des matériaux par l'emploi d'ondes ultrasonores, sonores ou infrasonoresVisualisation de l'intérieur d'objets par transmission d'ondes ultrasonores ou sonores à travers l'objet Détails
G01N 27/66 - Utilisation de l'onde ou de la radiation des particules pour ioniser un gaz, p. ex. dans une chambre d'ionisation et mesure de l'intensité ou de la tension électriques
Technion Research & Development Foundation Limited (Israël)
Inventeur(s)
Sagi, Yoav
Abrégé
An atomic interferometer system comprises optical tweezers each configured to trap at least one atom therein, an atom source system configured to release atoms, and a controller configured to control the optical tweezers to trap at least one atom released by the atom source system in one of the tweezers, to spatially split a wave function of the trapped atom between at least two of the tweezers, and to at least partially recombine the split atomic wave function in at least one of the tweezers. The atomic interferometer system can also comprise a measuring system configured to measure wavefunction population in each of the tweezers and to display an output pertaining to the wavefunction populations.
G01V 7/02 - Mesure de champs ou d'ondes de gravitationProspection ou détection gravimétrique Détails
G16C 10/00 - Chimie théorique computationnelle, c.-à-d. TIC spécialement adaptées aux aspects théoriques de la chimie quantique, de la mécanique moléculaire, de la dynamique moléculaire ou similaires
G21K 1/00 - Dispositions pour manipuler des particules ou des rayonnements ionisants, p. ex. pour focaliser ou pour modérer
H03L 7/26 - Commande automatique de fréquence ou de phaseSynchronisation utilisant comme référence de fréquence les niveaux d'énergie de molécules, d'atomes ou de particules subatomiques
20.
DEGRADABLE POLYMERIC COMPOSITIONS AND ARTICLES COMPRISING SAME
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israël)
Inventeur(s)
Davidovich-Pinhas, Maya
Rosen Kligvasser, Jasmine
Abrégé
The present invention provides a composition comprising (i) a cellulose-based polymer, and (ii) a plasticizer; wherein a weight per weight (w/w) concentration of the plasticizer within the composition is from 0.1 to 20%; and wherein a glass transition temperature (Tg) of the composition is reduced by at least 20% compared to a Tg of the cellulose-based polymer. Furthermore, provided herein are articles comprising the composition of the invention, and methods for manufacturing thereof.
Technion Research & Development Foundation Limited (Israël)
Inventeur(s)
Priebe, Gregory P.
Kishony, Roy
Chung, Hattie
Schaefers, Matthew M.
Abrégé
This disclosure relates to methods and compositions useful for detecting and monitoring low-frequency mutations. Methods and compositions described herein can be used to guide clinical decisions, for example, by informing on which antibiotics should be avoided, or conversely, which antibiotics should be actively used in the case of compounds that select against a specific type of resistance.
C12Q 1/689 - Produits d’acides nucléiques utilisés dans l’analyse d’acides nucléiques, p. ex. amorces ou sondes pour la détection ou l’identification d’organismes pour les bactéries
C12Q 1/6806 - Préparation d’acides nucléiques pour analyse, p. ex. pour test de réaction en chaîne par polymérase [PCR]
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israël)
Inventeur(s)
Vogt, Charlotte
Zisser Gal, Noam
Karo, Noam
Mayraz, Or
Licht, Assaf
Abrégé
Nanostructured electrodes comprising nanoparticles of conductive material deposited on a conductive electrode support are described in the present invention. Said nanoparticles are characterised by a particle size of about 20.0 nm or less and a particle size distribution having a tuneable standard deviation from ±0.1 nm to ±1.0 nm. This particle size distribution is measured using a differential mobility analyser. The nanostructured electrodes are manufactured by the method of spark ablation, which provides a scalable and viable way for producing widely different types of mixed nanoparticles. Most importantly, implementation of the spark ablation has the great advantage to combine a wider range of materials, thereby allowing the synthesis of mixed nanoparticles with virtually unlimited combinations and highly sharp particle size distribution control which is advantageous for high tunability of selectivity.
B22F 9/14 - Fabrication des poudres métalliques ou de leurs suspensionsAppareils ou dispositifs spécialement adaptés à cet effet par des procédés physiques en utilisant des décharges électriques
C02F 1/46 - Traitement de l'eau, des eaux résiduaires ou des eaux d'égout par des procédés électrochimiques
C02F 1/461 - Traitement de l'eau, des eaux résiduaires ou des eaux d'égout par des procédés électrochimiques par électrolyse
C02F 1/66 - Traitement de l'eau, des eaux résiduaires ou des eaux d'égout par neutralisationAjustage du pH
C25B 1/04 - Hydrogène ou oxygène par électrolyse de l'eau
C25B 11/052 - Électrodes comportant un substrat et un ou plusieurs revêtements électro-catalytiques
C25B 11/054 - Électrodes comportant des électro-catalyseurs sur un support
C25B 11/091 - Électrodes comportant des électro-catalyseurs sur un substrat ou un support caractérisées par le matériau électro-catalytique formé d’au moins un élément catalytique et d’au moins un composé catalytiqueÉlectrodes comportant des électro-catalyseurs sur un substrat ou un support caractérisées par le matériau électro-catalytique formé de plusieurs éléments catalytiques ou composés catalytiques
C25B 13/07 - DiaphragmesÉléments d'espacement caractérisés par le matériau à base de matériaux inorganiques à base de céramiques
Technion Research & Development Foundation Limited (Israël)
Inventeur(s)
Sharon, Simon
Boader, Idan
Shoham, Moshe
Cohen, Eran
Morag, Eyal
Abrégé
An assembly for driving linear movement and roll movement of an elongate surgical tool, comprising: an elongate shaft comprising a central lumen extending along the shaft long axis; the elongate shaft comprising a plurality of apertures extending across walls of the elongate shaft and into the central lumen; a set of wheels positioned opposing each other and aligned on two sides of the central lumen, the set of wheels at least partially extending through the apertures beyond the walls of the elongate shaft and into the central lumen to contact an elongate surgical tool received therein; the set of wheels being coupled to the elongate shaft and configured to rotate with the elongate shaft as a single unit when the elongate shaft is rotated about the shaft long axis.
A61B 1/00 - Instruments pour procéder à l'examen médical de l'intérieur des cavités ou des conduits du corps par inspection visuelle ou photographique, p. ex. endoscopesDispositions pour l'éclairage dans ces instruments
A61B 17/00 - Instruments, dispositifs ou procédés chirurgicaux
A61B 34/00 - Chirurgie assistée par ordinateurManipulateurs ou robots spécialement adaptés à l’utilisation en chirurgie
B01L 3/00 - Récipients ou ustensiles pour laboratoires, p. ex. verrerie de laboratoireCompte-gouttes
C12Q 1/24 - Méthodes d'échantillonnage, d'inoculation ou de développement d'un échantillonMéthodes pour isoler physiquement un micro-organisme intact
C12Q 1/6888 - Produits d’acides nucléiques utilisés dans l’analyse d’acides nucléiques, p. ex. amorces ou sondes pour la détection ou l’identification d’organismes
25.
THIN SHAPED STRUCTURAL ELEMENTS AND METHOD OF MAKING SAME
Technion Research & Development Foundation Limited (Israël)
Inventeur(s)
Pourati, Ryan
Larianovsky, Pavel
Ben Tur, Arnon
Grobman, Jacob
Shaked, Tom
Sprecher, Aaron
Weissman, Aharon
Masri, Bassam
Abrégé
Disclosed is a method of fabricating a construction element. The method may include assembling a mold on a rotational casting machine; rotating the mold around at least two axes at a predetermined speed; providing a first portion of magnesium silico-phosphate cement (MSPC) mix, having an altered hardening rate, to the mold while rotating the mold until at least a portion of the mold's walls is covered by a first layer of the MSPC mix; and rotating the mold until the MSPC mix is hardened to a predetermined degree.
B28B 1/20 - Fabrication d'objets façonnés à partir du matériau par coulée centrifuge ou rotative
C04B 20/00 - Emploi de matières comme charges pour mortiers, béton ou pierre artificielle prévu dans plus d'un groupe et caractérisées par la forme ou la répartition des grainsTraitement de matières spécialement adapté pour renforcer leur propriétés de charge dans les mortiers, béton ou pierre artificielle prévu dans plus d'un groupe de Matières expansées ou défibrillées
C04B 28/34 - Compositions pour mortiers, béton ou pierre artificielle, contenant des liants inorganiques ou contenant le produit de réaction d'un liant inorganique et d'un liant organique, p. ex. contenant des ciments de polycarboxylates contenant des liants phosphate froids
Technion Research & Development Foundation Limited (Israël)
Inventeur(s)
Diskin, David
Tartakovsky, Leonid
Abrégé
A hybrid system, including a solid-oxide fuel cell (SOFC), an internal combustion engine (ICE), and a thermochemical recuperation (TCR) unit. The TCR unit is configured to: (i) receive waist heat from the ICE, (ii) receive a primary fuel, (iii) perform a waste heat recovery process to provide reformed fuel. The SOFC is configured to receive a first part of the reformed fuel and convert the first part of the reformed fuel to electrical work. The ICE is configured to receive a second part of the reformed fuel and convert the second part of the reformed fuel to mechanical work.
Technion Research & Development Foundation Limited (Israël)
Inventeur(s)
Machluf, Marcelle
Bronshtein, Tomer
Abrégé
Compositions comprising liposomes composed of whole cell membrane fraction are provided. The liposomes may be attached to, or encapsulate a pharmaceutical agent. Also provided are methods of generating and using these liposomes.
A61K 9/127 - Vecteurs à bicouches synthétiques, p. ex. liposomes ou liposomes comportant du cholestérol en tant qu’unique agent tensioactif non phosphatidylique
A61K 47/69 - Préparations médicinales caractérisées par les ingrédients non actifs utilisés, p. ex. les supports ou les additifs inertesAgents de ciblage ou de modification chimiquement liés à l’ingrédient actif l’ingrédient non actif étant chimiquement lié à l’ingrédient actif, p. ex. conjugués polymère-médicament le conjugué étant caractérisé par sa forme physique ou sa forme galénique, p. ex. émulsion, particule, complexe d’inclusion, stent ou kit
C12N 15/88 - Introduction de matériel génétique étranger utilisant des procédés non prévus ailleurs, p. ex. co-transformation utilisant la micro-encapsulation, p. ex. utilisant des vésicules liposomiques
H01L 31/00 - Dispositifs à semi-conducteurs sensibles aux rayons infrarouges, à la lumière, au rayonnement électromagnétique d'ondes plus courtes, ou au rayonnement corpusculaire, et spécialement adaptés, soit comme convertisseurs de l'énergie dudit rayonnement e; Procédés ou appareils spécialement adaptés à la fabrication ou au traitement de ces dispositifs ou de leurs parties constitutives; Leurs détails
29.
DECOY PEPTIDES, COMPOSITIONS, METHODS AND USES THEREOF IN THE TREATMENT OF PROTEINOPATHIES
A61K 38/04 - Peptides ayant jusqu'à 20 amino-acides dans une séquence entièrement déterminéeLeurs dérivés
A61K 38/17 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'animauxPeptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'humains
C07K 14/47 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'animauxPeptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'humains provenant de vertébrés provenant de mammifères
A61P 25/28 - Médicaments pour le traitement des troubles du système nerveux des troubles dégénératifs du système nerveux central, p. ex. agents nootropes, activateurs de la cognition, médicaments pour traiter la maladie d'Alzheimer ou d'autres formes de démence
30.
METHOD OF DETERMINING FUSOGENIC POTENTIAL OF SPERM AND USE THEREOF IN ASSISTED FERTILIZATION AND DRUG SCREENING
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israël)
Inventeur(s)
Podbilewicz, Benjamin
Brukman, Nicolas Gaston
Valansi, Clari
Abrégé
A method of determining fusogenic potential of sperm is provided, The method comprising: (a) contacting a biological sample comprising sperm with somatic cells expressing ectopic JUNO under conditions which allow binding of the sperm to the JUNO; and subsequently (b) detecting multinucleation in the somatic cells, wherein a level of the multinucleation is indicative of the fusogenic potential of the sperm.
G01N 33/68 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique faisant intervenir des protéines, peptides ou amino-acides
G01N 33/48 - Matériau biologique, p. ex. sang, urineHémocytomètres
C12N 5/077 - Cellules mésenchymateuses, p. ex. cellules osseuses, cellules de cartilage, cellules stromales médulaires, cellules adipeuses ou cellules musculaires
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israël)
RAMBAM MED-TECH LTD. (Israël)
Inventeur(s)
Caspi, Oren
Haim, Idan Refael
Kazma, Noam
Abrégé
An isolated multicellular organoid comprising cardiomyocytes, endothelial cells, fibroblasts and smooth muscle cells is disclosed. The endothelial cells form part of a 3D endothelial structure, the cardiomyocytes of the organoid are capable of synchronized contractions, and epicardial cells of the organoid do not form a distinct layer in the organoid. Methods of maturing immature cardiomyocytes and use of cardiomyocytes for generating disease models are also disclosed.
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israël)
Inventeur(s)
Haick, Hossam
Abrégé
The disclosure provides a programmable, battery-less, autonomous and biodegradable smart dust particle (SDP) comprises: (i) a single layer or plurality of layers of a layered separating media for chromatographic separation of compounds contained in a sample subjected to the separation and for providing physical support for embedded electronics and for at least one detector; (ii) said at least one detector comprising an array of sensors printed on the layers of said separating media, and providing information on the presence and properties of said compounds in the sample; (iii) said embedded electronics printed on the layers of said separating media; and (iv) at least one radio-frequency identification (RFID) out-input tag for remote readout and zero-power operation, each RFID tag connected to said embedded electronics via an electric circuit for receiving or transmitting a signal. In addition, two systems comprising a plurality of the SDPs are disclosed: the first for autonomous analysis of an environmental sample and the second for tumour diagnosis. A method for diagnosing tumours and a wearable tomography device using the SDPs are also disclosed.
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israël)
Inventeur(s)
Kvatinsky, Shahar
Hodisan, Sariel
Abrégé
A device for signal acquisition, comprises a transimpedance amplifier having an input receiving a current from an input device, an output to supply an output voltage reflective of the current; and a memristor component connected in a feedback path of the transimpedance amplifier, the memristor component transitioning between a high resistive state and a low resistive state depending on a voltage difference across the memristor component. The gain of the transimpedance amplifier is reduced as the increase in current approaches a saturation level of the amplifier and triggers the transition. The result is an increase in dynamic range of the transimpedance amplifier to better match the range of current output that may be expected from say an optical input device.
Technion Research & Development Foundation Limited (Israël)
Rambam Med-Tech Ltd. (Israël)
Inventeur(s)
Rolls, Asya
Gepstein, Lior
Haykin, Hedva
Azulay-Debby, Hilla
Abrégé
Provided is reward system activation for therapeutic purposes. Accordingly there is provided a method of treating a disease in a subject in need thereof, the method comprising subjecting the subject to a treatment module which activates the reward system of the subject.
A61B 5/055 - Détection, mesure ou enregistrement pour établir un diagnostic au moyen de courants électriques ou de champs magnétiquesMesure utilisant des micro-ondes ou des ondes radio faisant intervenir la résonance magnétique nucléaire [RMN] ou électronique [RME], p. ex. formation d'images par résonance magnétique
35.
A METHOD AND SYSTEM FOR DETECTION AND ANALYSIS OF CHEMICAL COMPOUNDS IN A SAMPLE SUBJECTED TO A CHROMATOGRAPHIC SEPARATION ON A LAYERED SEPARATING MEDIUM
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israël)
Inventeur(s)
Haick, Hossam
Maity, Arnab
Abrégé
A method and system in the present invention allow to detect and analyse chemical compounds in a sample subjected to chromatographic separation on a layered medium. The system comprises a detector comprising an array of sensors printed on each layer of the separating medium, and providing information on the presence and properties of the tested compounds in the sample. The machine-learning methods used in the method of the invention are shown to be the methods of choice when analysing the spectrometry data, for example μGC data, in a variety of scenarios and in a variety of applications, including real-time molecular analysis. These machine-learning methods can effectively learn the spectroscopic and chromatographic models taking into account various kinetic and thermodynamic parameters and by that constitute an advantageous alternative to traditional spectroscopic and chromatographic analytical methods.
H05K 1/16 - Circuits imprimés comprenant des composants électriques imprimés incorporés, p. ex. une résistance, un condensateur, une inductance imprimés
H05K 3/12 - Appareils ou procédés pour la fabrication de circuits imprimés dans lesquels le matériau conducteur est appliqué au support isolant de manière à former le parcours conducteur recherché utilisant la technique de l'impression pour appliquer le matériau conducteur
36.
METHODS AND COMPOSITIONS FOR USE IN IMPROVING ADAPTIVE IMMUNITY IN THE ELDERLY POPULATION
Technion Research & Development Foundation Limited (Israël)
Inventeur(s)
Ron-Harel, Noga
Ezuz, David
Abrégé
A method of increasing proliferation of adaptive immune cells of a subject at least 65 years old is provided. The method comprising contacting the immune cells with an agent which increases the level of labile iron in the immune cells and/or reduces toxicity of hemoglobin, heme or a degradation product thereof, thereby increasing the proliferation of the adaptive immune cells of the subject.
A61K 39/39 - Préparations médicinales contenant des antigènes ou des anticorps caractérisées par les additifs immunostimulants, p. ex. par les adjuvants chimiques
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israël)
NEW YORK SOCIETY FOR THE RELIEF OF THE RUPTURED AND CRIPPLED, MAINTAINING THE HOSPITAL FOR SPECIAL (USA)
Inventeur(s)
Kimmel, Ron
Groisser, Benjamin
Wolf, Alon
Widmann, Roger F.
Hillstrom, Howard J.
Abrégé
A method comprising: receiving a radiographic image dataset representing a sequential radiographic scan of a region of a human subject; receiving three-dimensional (3D) image data representing an optical scan of a surface of said region, wherein said 3D image data is performed simultaneously with said sequential radiographic scan; estimating a time-dependent motion of said subject during said acquisition, relative to a specified position, based, at least in part, on said 3D image data; and using said estimating to determine corrections for said radiographic image dataset, based, at least in part, on a known transformation between corresponding coordinate systems of said radiographic image dataset and said 3D image data.
A61B 6/00 - Appareils ou dispositifs pour le diagnostic par radiationsAppareils ou dispositifs pour le diagnostic par radiations combinés avec un équipement de thérapie par radiations
G06T 7/246 - Analyse du mouvement utilisant des procédés basés sur les caractéristiques, p. ex. le suivi des coins ou des segments
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israël)
Inventeur(s)
Geva-Zatorsky, Naama
Gefen, Tal
Kariti, Dana
Ben-Assa, Nadav
Abboud, Robert
Carasso, Shaqed
Zaatry, Rawan
Abrégé
The present disclosure relates to the microbiome field. More specifically, the present disclosure relates to bacteriophages as a tool to manipulate gut immune-modulatory activity and uses thereof for therapy. More specifically, the present disclosure provides methods and tools for modulating an immune response in a subject in need thereof, by applying bacteriophage that modulates the phenotype of at least one bacteria in a subject.
A61K 48/00 - Préparations médicinales contenant du matériel génétique qui est introduit dans des cellules du corps vivant pour traiter des maladies génétiquesThérapie génique
A61K 35/66 - Micro-organismes ou substances provenant de micro-organismes
Technion Research & Development Foundation Limited (Israël)
Inventeur(s)
Kvatinsky, Shahar
Wainstein, Nicolas
Yalon, Eilam
Abrégé
An indirectly heated phase change switch (IPCS) for radio frequency (RF) switching, comprises two RF ports and an RF path therebetween, a phase change material (PCM) located between the RF ports, an embedded heater separated from the PCM by a dielectric layer, the embedded heater configured to provide thermal actuation of the PCM to bring about phase changes between a crystalline state and an amorphous state to provide Ohmic switching, and a bias voltage on the IPCS across said RF path. The bias is provided during heating to improve the crystallization time.
H03K 17/51 - Commutation ou ouverture de porte électronique, c.-à-d. par d'autres moyens que la fermeture et l'ouverture de contacts caractérisée par l'utilisation de composants spécifiés
H03K 3/01 - Circuits pour produire des impulsions électriquesCircuits monostables, bistables ou multistables Détails
40.
COMPOSITIONS AND METHODS FOR TREATING A MEDICAL CONDITION
Technion Research & Development Foundation Limited (Israël)
Inventeur(s)
Melamed, Philippa
Polinsky, Lilach Pnueli
Abrégé
Compositions and methods for treating a medical condition are provided. Accordingly, there is provided a composition comprising a polypeptide comprising a GnRH receptor binding protein and a polynucleotide coding a therapeutic agent, wherein said polypeptide is in association with said polynucleotide via a linker comprising a cleavage motif that can be cleaved by a proteolytic enzyme secreted by a cell expressing said GnRH receptor. Also provided is a nucleic acid construct comprising a nucleic acid sequence encoding a fusion protein comprising a DNA binding domain (DBD) of a transcription factor that binds a regulatory region of a gonadotropin gene attached to a chromatin modifying domain that represses transcription upon association with the DBD. Also provided are methods of use thereof.
Technion Research & Development Foundation Limited (Israël)
Inventeur(s)
Soljacic, Marin
Kaminer, Ido
Rivera, Nicholas
Sloan, Jamison
Salamin, Yannick
Abrégé
A principle which enables the generation of macroscopic Fock and sub-Poissonian states is disclosed. Generic components of the system include: an electromagnetic structure (possessing one or more electromagnetic resonances), a nonlinear electromagnetic element (such as a nonlinear crystal near or inside the structure), and a source of light. In one embodiment, stimulated gain is used to create large numbers of photons in a cavity, but with very low photon number noise (uncertainty) in the cavity, and thus acts as a Fock laser. This Fock laser is capable of producing these states due to a very sharp intensity-dependent gain (or loss) that selects a particular photon number. The disclosed system and method are robust against both atomic and optical decoherence. Various examples of the new Fock laser design are also described.
C08J 11/12 - Récupération ou traitement des résidus des polymères par coupure des chaînes moléculaires des polymères ou rupture des liaisons de réticulation par voie chimique, p. ex. dévulcanisation uniquement par traitement à la chaleur sèche
B29B 17/04 - Désintégration des matières plastiques
43.
REVERSIBLE BACTERIAL PHSE-VARIATIONS AND USES THEREOF IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israël)
MIGAL GALILEE RESEARCH INSTITUTE LTD. (Israël)
Inventeur(s)
Geva-Zatorsky, Naama
Carasso, Shaqed
Gefen, Tal
Keshet, Roni
Hajjo, Haitham
Zaatry, Rawan
Sharon, Itai
Abrégé
The present disclosure relates to reversible phase variations in bacteria e.g., residing in a microbiome or any environment, and uses thereof in determining a physiological and/or environmental condition or state of a subject or a media and/or or habitat. The present disclosure thus provides methods and personalized therapeutic methods and kits.
C12Q 1/04 - Détermination de la présence ou du type de micro-organismeEmploi de milieux sélectifs pour tester des antibiotiques ou des bactéricidesCompositions à cet effet contenant un indicateur chimique
C12Q 1/02 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismesCompositions à cet effetProcédés pour préparer ces compositions faisant intervenir des micro-organismes viables
A61P 29/00 - Agents analgésiques, antipyrétiques ou anti-inflammatoires non centraux, p. ex. agents antirhumatismauxMédicaments anti-inflammatoires non stéroïdiens [AINS]
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israël)
NEW YORK SOCIETY FOR THE RELIEF OF THE RUPTURED AND CRIPPLED, MAINTAINING THE HOSPITAL FOR SPECIAL SURGERY (USA)
Inventeur(s)
Kimmel, Ron
Groisser, Benjamin
Wolf, Alon
Widmann, Roger F.
Hillstrom, Howard J.
Abrégé
A method comprising: generating a parametrized three-dimensional (3D) body surface model on a training set comprising a plurality of 3D scans of subjects, wherein at least some of said 3D scans are of subjects having a skeletal deformity; receiving one or more target 3D scans of a target subject; optimizing said body surface model with respect to said one or more target 3D scans to calculate a target body surface model of said target subject; training a skeletal estimation model on a training set comprising: (i) body surface models of a plurality of subjects, and (ii) skeletal landmarks sets of said plurality of subjects; and applying said trained skeletal estimation model to said calculated target body surface model of said target subject, to estimate a skeletal shape of said target subject.
Technion Research & Development Foundation Limited (Israël)
Inventeur(s)
Bohana-Kashtan, Osnat
Pinkas, Oded
Gotliv, Irina
Tsubery, Haim
Kopelman, Tal Yoetz
Chaim, Neta
Avni, Noa
Liandres, Hanna
Govrin, Roy
Malca, Yonatan
Machluf, Marcelle
Amsalem-Bergelson, Orit
Abrégé
A method of producing spherical particles is provided herein. Also provided are compositions generated thereby and uses thereof in disease diagnosis and treatment.
C12M 1/00 - Appareillage pour l'enzymologie ou la microbiologie
A61K 9/48 - Préparations en capsules, p. ex. de gélatine, de chocolat
C12N 5/00 - Cellules non différenciées humaines, animales ou végétales, p. ex. lignées cellulairesTissusLeur culture ou conservationMilieux de culture à cet effet
Technion Research & Development Foundation Limited (Israël)
Inventeur(s)
Shechtman, Yoav
Ferdman, Boris
Opatovski, Nadav
Nehme, Elias
Kedem, Reut
Abrégé
An objective lens system comprises a set of lenses, arranged along a common optical axis to form a back focal plane. The objective lens system also comprises an optical mask at the back focal plane, and a housing encapsulating the set of lenses and the optical mask.
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israël)
Inventeur(s)
Schroeder, Avi
Sela, Mor
Abrégé
In one aspect of the invention, there is provided a nanoparticle comprising a core and a shell, wherein the core comprises a bioactive compound, and the shell comprises a lipid layer comprising a first modified lipid and a additional lipid, wherein the first modified lipid is bound to a targeted moiety via a spacer, and wherein the additional lipid comprises a polymer-bound lipid. The present invention further provides pharmaceutical compositions and methods for therapeutic and/or diagnostic use.
A61K 47/69 - Préparations médicinales caractérisées par les ingrédients non actifs utilisés, p. ex. les supports ou les additifs inertesAgents de ciblage ou de modification chimiquement liés à l’ingrédient actif l’ingrédient non actif étant chimiquement lié à l’ingrédient actif, p. ex. conjugués polymère-médicament le conjugué étant caractérisé par sa forme physique ou sa forme galénique, p. ex. émulsion, particule, complexe d’inclusion, stent ou kit
Technion Research & Development Foundation Limited (Israël)
Inventeur(s)
Hacohen-Gourgy, Shay
Diringer, Asaf A.
Abrégé
A method for displacement of an electromagnetic mode (EM) conditioned on the state of an ancilla qubit, the method may include displacing, by applying a displacement operation, an EM mode whose frequencies are conditioned on the state of the ancilla qubit and are spaced apart by a frequency difference, by providing a displacement signal having a bandwidth that exceeds the frequency difference and has a zero amplitude at one or more of the frequencies of the electromagnetic mode which are defined by the displacement operation not to be displaced and a non-zero amplitude at one or more frequencies of the mode which are defined by the displacement operation to be displaced.
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israël)
Inventeur(s)
Shaked, Yuval Yechiel
Schroeder, Avi
Menachem, Rotem
Abrégé
Nanoparticles comprising an outer surface covalently conjugated to 1,4-Bis[(1,4,8,11-tetraazacyclotetradecan-l-yl)methyl]benzene (AMD3100) or a derivative thereof capable of binding to C-X-C chemokine receptor type 4 (CXCR4) are provided. Methods for of treating a CXCR4 positive cancer, such as multiple myeloma or acute myeloid leukemia, in a subject in need thereof, methods of determining suitability for treatment and methods of covalently linking a molecule comprising a secondary amine to a lipid nanoparticle, are also provided.
A61K 47/64 - Conjugués médicament-peptide, médicament-protéine ou médicament-acide polyaminé, c.-à-d. l’agent de modification étant un peptide, une protéine ou un acide polyaminé lié par covalence ou complexé à un agent thérapeutiquement actif
A61K 38/04 - Peptides ayant jusqu'à 20 amino-acides dans une séquence entièrement déterminéeLeurs dérivés
C07K 14/715 - RécepteursAntigènes de surface cellulaireDéterminants de surface cellulaire pour des cytokinesRécepteursAntigènes de surface cellulaireDéterminants de surface cellulaire pour des lymphokinesRécepteursAntigènes de surface cellulaireDéterminants de surface cellulaire pour des interférons
A61K 31/255 - Esters, p. ex. nitroglycérine, sélénocyanates d'acides oxygénés du soufre ou de leurs thio-analogues
A61K 31/565 - Composés contenant des systèmes cycliques du cyclopenta[a]hydrophénanthrèneLeurs dérivés, p. ex. stéroïdes non substitués en position 17 bêta par un atome de carbone, p. ex. œstrane, œstradiol
A61K 31/00 - Préparations médicinales contenant des ingrédients actifs organiques
A61K 38/00 - Préparations médicinales contenant des peptides
A61K 47/69 - Préparations médicinales caractérisées par les ingrédients non actifs utilisés, p. ex. les supports ou les additifs inertesAgents de ciblage ou de modification chimiquement liés à l’ingrédient actif l’ingrédient non actif étant chimiquement lié à l’ingrédient actif, p. ex. conjugués polymère-médicament le conjugué étant caractérisé par sa forme physique ou sa forme galénique, p. ex. émulsion, particule, complexe d’inclusion, stent ou kit
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israël)
RAMBAM MED-TECH LTD, (Israël)
Inventeur(s)
Gepstein, Lior
Wexler, Yehuda
Abrégé
Nucleic acid molecules comprising a first sequence encoding a cyclic nucleotide gated potassium channel or a functional fragment thereof and a second sequence encoding a chemogenetically activatable cyclic adenosine monophosphate (cAMP) generating receptor or a functional fragment thereof are provided. Expression vectors comprising the molecules, fusion proteins encoded by the molecules, cells, kits and pharmaceutical compositions are also provided. Methods of hyperpolarizing a cell, depolarizing a cardiac cell and treating a disease or condition are also provided.
C12N 15/62 - Séquences d'ADN codant pour des protéines de fusion
A61K 38/17 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'animauxPeptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'humains
C07K 14/705 - RécepteursAntigènes de surface cellulaireDéterminants de surface cellulaire
Technion Research & Development Foundation Limited (Israël)
Inventeur(s)
Bekenstein, Yehonadav
Strassberg, Rotem
Abrégé
A method of fabricating a light emitting device, comprises mixing a first solution containing a polymeric component with a second solution containing quantum-confinement structures, to provide a solution mixture, and dispensing the solution mixture to form a fiber. The fiber is allow to be self-drawn such that at least one section of the fiber has a reduced diameter relative to another section.
H01L 33/56 - Matériaux, p.ex. résine époxy ou silicone
B29C 64/118 - Procédés de fabrication additive n’utilisant que des matériaux liquides ou visqueux, p. ex. dépôt d’un cordon continu de matériau visqueux utilisant un matériau filamentaire mis en fusion, p. ex. modélisation par dépôt de fil en fusion [FDM]
B29K 27/12 - Utilisation de polyhalogénures de vinyle comme matière de moulage contenant du fluor
B29K 33/00 - Utilisation de polymères d'acides non saturés ou de leurs dérivés comme matière de moulage
B29K 105/00 - Présentation, forme ou état de la matière moulée
D01D 5/00 - Formation des filaments, fils ou similaires
D01F 1/10 - Autres agents modifiant les propriétés de ces filaments
D01F 6/12 - Filaments, ou similaires, faits par l’homme, à un seul composant, formés de polymères synthétiquesLeur fabrication à partir d'homopolymères obtenus par des réactions faisant intervenir uniquement des liaisons non saturées carbone-carbone à partir de polymères d'hydrocarbures halogénés à partir de polymères d'hydrocarbures fluorés
D01F 6/16 - Filaments, ou similaires, faits par l’homme, à un seul composant, formés de polymères synthétiquesLeur fabrication à partir d'homopolymères obtenus par des réactions faisant intervenir uniquement des liaisons non saturées carbone-carbone à partir de polymères d'acides carboxyliques non saturés ou de polymères d'esters organiques non saturés, p. ex. à partir d'esters polyacryliques, d'acétate de polyvinyle
H01L 33/58 - DISPOSITIFS À SEMI-CONDUCTEURS NON COUVERTS PAR LA CLASSE - Détails caractérisés par les éléments du boîtier des corps semi-conducteurs Éléments de mise en forme du champ optique
52.
HEAT-TRANSFER-LIQUID-OPERATED TURBINE AND COMPRESSOR
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israël)
Inventeur(s)
Rotschild, Carmel
Cassell, Joseph
Abrégé
An energy storage and retrieval system including an air chamber, a first air compressor operating with Heat Transfer Liquid (HTL-compressor) connected to the air chamber, a second turbine, operating with Heat Transfer Liquid (HTL-turbine) connected to the air chamber, accepting compressed air from the air chamber and producing work. Related apparatus and methods are also described.
H02K 7/18 - Association structurelle de génératrices électriques à des moteurs mécaniques d'entraînement, p. ex. à des turbines
B01D 53/14 - Séparation de gaz ou de vapeursRécupération de vapeurs de solvants volatils dans les gazÉpuration chimique ou biologique des gaz résiduaires, p. ex. gaz d'échappement des moteurs à combustion, fumées, vapeurs, gaz de combustion ou aérosols par absorption
B01D 53/92 - Épuration chimique ou biologique des gaz résiduaires des gaz d'échappement des moteurs à combustion
F02C 6/18 - Utilisation de la chaleur perdue dans les ensembles fonctionnels de turbines à gaz à l'extérieur des ensembles eux-mêmes, p. ex. ensembles fonctionnels de chauffage à turbine à gaz
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israël)
Inventeur(s)
Green, Dor
Schechter, Israel
Abrégé
A method and system for detecting a state of an egg. Scan values are obtained for multiple scan locations on a shell of an egg, irradiation angles, and/or collection angles, at each the egg is irradiated and reflectance and/or emission is captured at a collection point and measured by a time¬ gated detector for one or more arrival times relative to an irradiation time. The scan values are analyzed to determine information of the egg's germinal disc and a state of the egg is determined according to the information.
G01N 21/25 - CouleurPropriétés spectrales, c.-à-d. comparaison de l'effet du matériau sur la lumière pour plusieurs longueurs d'ondes ou plusieurs bandes de longueurs d'ondes différentes
G01N 21/31 - CouleurPropriétés spectrales, c.-à-d. comparaison de l'effet du matériau sur la lumière pour plusieurs longueurs d'ondes ou plusieurs bandes de longueurs d'ondes différentes en recherchant l'effet relatif du matériau pour les longueurs d'ondes caractéristiques d'éléments ou de molécules spécifiques, p. ex. spectrométrie d'absorption atomique
G01N 21/63 - Systèmes dans lesquels le matériau analysé est excité de façon à ce qu'il émette de la lumière ou qu'il produise un changement de la longueur d'onde de la lumière incidente excité optiquement
G01N 21/17 - Systèmes dans lesquels la lumière incidente est modifiée suivant les propriétés du matériau examiné
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israël)
Inventeur(s)
Avital, Avraham
Brand, Zev
Abrégé
Provided are methods for diagnosing or selecting a mammal in need of a stimulant ADHD drug, conducting a non-specific electro-dermal responses (EDAs) analysis and/or an auditory sustained attention (ASAT) analysis on the mammal and administering or adjusting the dose of a stimulant ADHD drug to be administered to the mammal.
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israël)
Inventeur(s)
Wolf, Alon
Zelnik-Manor, Lihi
Herbst, Yair
Chechik, Yoni
Abrégé
A haptic feedback device is disclosed. The haptic feedback device may include at least one texture emulator; a housing at least partially containing the texture emulator; and a controller configured to: receive instructions to provide a texture sensation; and control the texture emulator to apply force to at least one location on a surface based on the received instructions.
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israël)
Inventeur(s)
Amdursky, Nadav
Kumar Sarkar, Amit
Abrégé
A solid hydrogel material comprising a plant-based protein and the agent is provided, wherein the agent is selected from a carboxylic acid and glycol or combination thereof. Further, articles comprising the hydrogel of the invention are also provided.
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israël)
Inventeur(s)
Mizrahi, Boaz
Freundlich, Eden
Shimony, Neta
Abrégé
A polymeric article comprising a plurality of convergent vertical structures bound to a support, wherein the article is composed of (i) a non-crosslinked biodegradable polymer, (ii) a crosslinked polymer, and (iii) a tissue-adhesive polymer, and use thereof such as for sealing a biological tissue is provided.
A61M 37/00 - Autres appareils pour introduire des agents dans le corpsPercutanisation, c.-à-d. introduction de médicaments dans le corps par diffusion à travers la peau
A61M 31/00 - Dispositifs pour l'introduction ou la rétention d'agents, p. ex. de remèdes, dans les cavités du corps
A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED. (Israël)
Inventeur(s)
Sprecher, Aaron
Nix, Tamar
Dahan, Yehiel
Abrégé
A crocheting device is disclosed, configured to receive a continuous feed of textile material and produce therefrom a crochet structure. The device comprising a feed mechanism configured to receive a portion of the textile material and regulate tension thereof, a looping mechanism configured to draw tensioned textile material from the feed mechanism and form one or more loops therefrom, and a crocheting mechanism configured to receive the one or more loops from the looping mechanism and successively interlock them to one or more loops of the produced crochet structure.
D04B 35/16 - Dispositifs indicateurs, avertisseurs ou de sécurité, p. ex. mouvements d'arrêt sensibles aux cassures de fil avec détecteurs associés à une série de fils
59.
METHODS AND COMPOSITIONS FOR TREATMENT OF VIRAL INFECTION
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israël)
Inventeur(s)
Amit, Roee
Goldberg, Sarah
Granik, Naor
Kikuchi, Nanami
Willinger, Or
Kitchen, Patricia
Abrégé
RNA-protein granules comprising fusion proteins and RNA are disclosed, as well as uses thereof for treating or preventing viral infection. Soluble fusion proteins comprising an extracellular domain of a human receptor or a fragment thereof and a bacteriophage coat protein, as well as synthetic microcarriers comprising a solid support conjugated to a plurality of viral proteins or fragments thereof are provided. Nucleic acid molecules and vectors encoding the soluble fusion protein, synthetic RNA-protein granules comprising a fusion protein, as well as method using the soluble fusion protein are also provided.
Technion Research & Development Foundation Limited (Israël)
Inventeur(s)
Freiman, Mordechay Pinchas
Nemirovsky-Rotman, Shira
Abrégé
A method for estimating parameters of a model that is non-linear and is more complex than a log-linear model, the method may include feeding measured observations and sampling coordinates of the measured observations to a machine learning process; and processing the measured observations and the sampling coordinates of the measured observations, by the machine learning process, to provide an estimate of the parameters of the model; wherein the model is indicative of a relationship between the measured observations and the sampling coordinates.
Technion Research & Development Foundation Limited (Israël)
Inventeur(s)
Machluf, Marcelle
Fishman, Ayelet
Davidovich-Pinhas, Maya
Baruch, Limor
Zernov, Anton
Glusac, Jovana
Abrégé
Compositions-of-matter containing a plurality of edible microstructures (e.g., microparticles) made of a plant protein extract, composites containing such compositions-of-matter and cells adhered to the microstructures, and processes of preparing same, are provided. Also provided are food products containing these composites and methods of preparing same.
C12N 5/00 - Cellules non différenciées humaines, animales ou végétales, p. ex. lignées cellulairesTissusLeur culture ou conservationMilieux de culture à cet effet
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israël)
Inventeur(s)
Rotschild, Carmel
Cassell, Joseph
Abrégé
A method for converting heat to mechanical work includes providing incoming heat transfer liquid (HTL) at a first temperature to a plurality of mixing chambers, providing incoming compressed gas at a second temperature to the plurality of mixing chamber, enabling the gas and the HTL to mix, producing a gas-and-HTL mix, enabling the HTL in the gas-and-HTL mix to heat the gas and isothermal expansion of the gas in the gas-and-HTL mix, limiting volume of the gas-and-HTL mix, thereby increasing pressure of the gas and causing acceleration of a flow of the gas-and-HTL mix, causing the gas-and-HTL mix to eject through a plurality of nozzles, thereby converting the heat of the HTL to kinetic energy to cause movement of the plurality of nozzles; and using the kinetic energy to produce mechanical work.
F01K 27/00 - Ensembles fonctionnels transformant la chaleur ou l'énergie d'un fluide en énergie mécanique, non prévus ailleurs
F01K 21/04 - Ensembles fonctionnels de machines motrices à vapeur non prévus ailleurs utilisant un mélange de vapeur et de gazEnsembles fonctionnels produisant ou surchauffant de la vapeur en mettant en contact direct l'eau ou la vapeur avec des gaz chauds
F01K 25/06 - Ensembles fonctionnels ou machines motrices caractérisés par l'emploi de fluides énergétiques particuliers non prévus ailleursEnsembles fonctionnant selon un cycle fermé, non prévus ailleurs utilisant un mélange de fluides différents
63.
COMPACT ROBOTIC DEVICE AND ASSEMBLIES FOR MANIPULATION OF ELONGATE SURGICAL TOOLS
Technion Research & Development Foundation Limited (Israël)
Inventeur(s)
Sharon, Simon
Boader, Idan
Kofman, Evgeny
Sohn, Zev
Shoham, Moshe
Cohen, Eran
Morag, Eyal
Abrégé
An assembly for driving movement of an elongate surgical tool, comprising:
An assembly for driving movement of an elongate surgical tool, comprising:
a plurality of adjacent pairs of driving wheels, each pair of driving wheels having a space therebetween such that spaces of the plurality of pairs of driving wheels are axially aligned to form a channel for the elongate surgical tool to extend through;
wherein at least one pair of driving wheels out of the plurality of pairs is arranged to lie on a plane different than a plane on which at least one other pair of driving wheels lies.
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israël)
YEDA RESEARCH AND DEVELOPMENT CO. LTD. (Israël)
Inventeur(s)
Schroeder, Avraham
Abel, Ravit
Eldar, Yonina
Eder, Yonathan
Abrégé
A system and method is presented for imaging a biological tissue, marked by metal particles, in at least one region of interest in the biological tissue. The system comprises: a frequency modulated continuous wave (FMCW) transceiver system comprising at least one radiation transmitter and at least one radiation receiver, the FMCW transceiver being configured to transmit series of millimeter wavelength signals to interact with each of said at least one region of interest and receive radiation originated within a field of view of the transceiver, and generate raw measured data indicative of received radiation; and a control system configured and operable to receive and process said raw measured data, the processing comprising extracting from said raw measured data, data indicative of radiation response of said metal particles to said interaction with the millimeter wavelength signals for each of said at least one region of interest, and determining map data indicative of a distribution of said metal particles within each region of interest.
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israël)
Inventeur(s)
Meller, Amit
Marom, Yulia
Chandra Verma, Navneet
Abrégé
Systems for detecting fluorescence from a molecule comprising an ion-impermeable film comprising at least one ion-conducting nanopore and a laser coupling slot; a first and second liquid reservoir separated by the film; a means to induce movement of the molecule from the first reservoir to the second reservoir via the nanopore; a light source capable of exciting the molecule to emit fluorescence, wherein the light source shines into the second reservoir; a metallic layer adhered to the film by an adhesion layer and comprising a nanowell structure located adjacent to the nanopore; and a detector configured to detect the fluorescence emitted by the molecule are provided. Methods of use of the systems are also provided.
G01N 21/63 - Systèmes dans lesquels le matériau analysé est excité de façon à ce qu'il émette de la lumière ou qu'il produise un changement de la longueur d'onde de la lumière incidente excité optiquement
G01N 33/487 - Analyse physique de matériau biologique de matériau biologique liquide
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israël)
Inventeur(s)
Meller, Amit
Ohayon, Shilo
Taib, Liran
Abrégé
Methods of determining the identity of a protein of interest within a sample comprising running the sample through a porous media within a nanochannel, determining a dynamic trajectory of the protein of interest as it moves through the porous media, measuring abundance of at least one amino acid in the protein and determining the protein's identity based on the abundance of the amino acid and at least one parameter calculated from the dynamic trajectory; are provided. Methods of detecting a protein in a stream of images taken of a porous media in a nanochannel are also provided.
G01N 33/487 - Analyse physique de matériau biologique de matériau biologique liquide
G01N 33/58 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique faisant intervenir des substances marquées
G01N 33/68 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique faisant intervenir des protéines, peptides ou amino-acides
B01D 57/02 - Séparation, autre que la séparation de solides, non entièrement couverte par un seul groupe ou sous-classe, p. ex. par électrophorèse
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israël)
Inventeur(s)
Agnon, Yehuda
Ramon, Guy
Meir, Avishai
Abrégé
A thermoacoustic device that includes a resonator, wherein the resonator includes a stack. During operation, a cold zone of the stack is configured to receive at least one fluid from a hot zone of the stack; wherein a temperature of the hot zone exceeds a temperature of the cold zone. The thermoacoustic device also includes a conveyor for conveying at least some of the at least one fluid from the cold zone of the stack to the hot zone of the stack.
F25B 9/00 - Machines, installations ou systèmes à compression dans lesquels le fluide frigorigène est l'air ou un autre gaz à point d'ébullition peu élevé
F25B 27/00 - Machines, installations ou systèmes utilisant des sources d'énergie particulières
F25B 23/00 - Machines, installations ou systèmes ayant un seul principe de fonctionnement non compris dans les groupes , p. ex. utilisant l'effet de radiation sélective
68.
CANNABINOIDS AND USES THEREOF IN TREATMENT OF A DISEASE
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israël)
Inventeur(s)
Meiri, Dedi
Fuchs, Yaron
Koren, Elle
Sedov, Egor
Abrégé
The present invention provides a pharmaceutical composition including a combination of one or more cannabinoids, and a methods of using same, such as for treating any one of: a wound, regenerating skin, alopecia, an inflammatory skin disease, a sebaceous gland proliferative disease, and any disorder, condition, or symptom associated therewith.
A61P 17/02 - Médicaments pour le traitement des troubles dermatologiques pour traiter les blessures, les ulcères, les brûlures, les cicatrices, les cheloïdes, ou similaires
Technion Research & Development Foundation Limited (Israël)
Inventeur(s)
Nazarathy, Moshe
Kodanev, Anna
Abrégé
An optical frequency sensor that includes (i) a heterodyne modulation and splitting unit that is configured to receive a first laser signal, modulate the first laser signal to provide a modulated laser signal and split the modulated laser signal to provide pre-processed optical signals; (ii) a self-coherent interferometer that includes (ii.1) a first optical processor that is configured to process the pre-processed optical signals to provide processed optical signals, and (ii.2) a detection unit that is configured to electro-optically mix the processed optical signals and photodetect an outcome of the mixing to provide detection signalsm and (iii) a signal processor configured to process the one or more digital signals to provide digital information about the first laser signal.
G01J 3/32 - Mesure de l'intensité des raies spectrales directement sur le spectre lui-même en étudiant des bandes d'un spectre successivement à l'aide d'un détecteur unique
70.
SYSTEM AND METHOD FOR RESOLUTION IMPROVEMENT OF CHARGED PARTICLES MICROSCOPY
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israël)
Inventeur(s)
Dahan, Raphael
Kaminer, Ido
Yannai, Michael
Fishman, Tal
Abrégé
A charged particles beam column for inspecting a sample in a sample plane is presented. The charged particles beam column comprises: a charged particles source generating a charged particles beam propagating along a general propagation path towards the sample plane; and at least one charged particles beam shaping unit. The charged particles shaping unit comprises at least one high-frequency electromagnetic radiation generator located in a vicinity of said general propagation path of the charged particles beam and controllably operated to perform synchronized generation of said high-frequency electromagnetic radiation towards at least one interaction region in said general propagation path, to cause interaction between said radiation and the charged particles, thereby directly affecting energy properties of the charged particles passing through said at least one interaction region in the general propagation path and directly affecting spectral resolution of the charged particles beam at said sample plane.
Technion Research & Development Foundation Limited (Israël)
Inventeur(s)
Ein-Eli, Yair
Amdursky, Nadav
Abrégé
The present invention discloses a slurry for electrode preparation, relevant to the field of electrode fabrication for various applications, which consists of an active material, a conductive additive, and a binder composition that includes a proteinaceous substance that may comprise amino acids, peptides, and/or proteins. The instantly disclosed slurry is useful in electrode fabrication, especially in the context of Li batteries. The process for preparing the electrode includes applying the slurry to a current collector and thermally treating the slurry, ensuring a durable and reliable electrode.
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israël)
Inventeur(s)
Sagi, Roy
Schlagman, Zohar
Abrégé
The present invention provides kits and compositions for e.g., hypergolic ignition of rocket propellant. The disclosed kits and the compositions comprise inter alia a fuel, a gelling agent, and an ignition agent; wherein the ignition agent is stably dissolved within the fuel.
C06B 27/00 - Compositions contenant un métal, le bore, le silicium, le sélénium ou le tellure ou leurs mélanges, intercomposés ou hydrures avec des hydrocarbures ou des hydrocarbures halogénés
C06B 23/00 - Compositions caractérisées par des constituants non explosifs ou non thermiques
C06B 47/02 - Compositions dans lesquelles les composants sont conservés séparément jusqu'au moment de l'explosion ou de la combustion, p. ex. explosifs du type "Sprengel"Suspensions d'un composant solide dans une phase liquide normalement non explosive, y compris une phase aqueuse épaissie les composants comportant un propergol binaire
73.
MODULATORS OF PROTEASOME DYNAMICS AND/OR FUNCTION, COMPOSITIONS, METHODS, AND THERAPEUTIC USES THEREOF
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israël)
Inventeur(s)
Ciechanover, Aaron
Livneh, Ido
Cohen-Kaplan, Victoria
Fabre, Bertrand Francois
Abrégé
The present disclosure provides modulators of proteasome dynamics and/or function in a mammalian cell, compositions and uses thereof. The disclosed modulating compounds are characterized by affecting at least one of: mammalian target of rapamycin (mTOR) activation and/or lysosomal association, proteasome cellular localization, the activity and/or level/s and/or the post translational modification/s (PTM/s), and/or subcellular localization of at least one signaling molecule participating directly or indirectly in at least one pathway mediating said proteasome dynamics/function.
G01N 33/50 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique
74.
HETEROSTRUCTURE HAVING NON-VOLATILE ACTUATABLE POLARIZATION
Technion Research & Development Foundation Limited (Israël)
Inventeur(s)
Koren, Elad
Dutta, Debopriya
Mukherjee, Subhrajit
Abrégé
A heterostructure system comprises a two-dimensional ferroelectric material on a dielectric substrate, and a two-dimensional semiconductor material having a first region disposed on the ferroelectric material and a second region disposed on the dielectric substrate, wherein an edge of the ferroelectric material is between the first region and the second region of the semiconductor material.
H01L 31/113 - Dispositifs sensibles au rayonnement infrarouge, visible ou ultraviolet caractérisés par un fonctionnement par effet de champ, p.ex. phototransistor à effet de champ à jonction du type conducteur-isolant-semi-conducteur, p.ex. transistor à effet de champ métal-isolant-semi-conducteur
H01L 31/032 - Matériaux inorganiques comprenant, à part les matériaux de dopage ou autres impuretés, uniquement des composés non couverts par les groupes
H01L 31/18 - Procédés ou appareils spécialement adaptés à la fabrication ou au traitement de ces dispositifs ou de leurs parties constitutives
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israël)
Inventeur(s)
Assaraf, Yehuda G.
Livney, Yoav D.
Cohen, Lital
Abrégé
This invention, in some embodiments thereof, provides a core-shell nanoparticle including a lipid-PSMA conjugate, encapsulating a liquid oil-based core. The invention further provides aqueous compositions including the core-shell nanoparticles, and methods for using same, such as for the treatment of proliferative diseases associated with PSMA upregulated expression.
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israël)
Inventeur(s)
Rotschild, Carmel
Abrégé
A system permitting efficient heat pump, storage of thermal energy, and retrieval of this stored thermal energy back to electricity upon demand. The system operates in two operational modes: a charging operational mode, in which thermal energy is pumped in an electrically driven compressor and is transferred into a hot heat transfer liquid reservoir by a heat transfer liquid; and a discharging operational mode, in which thermal energy from the hot reservoir is utilized in a turbine to produce kinetic energy that can be used directly or can be converted into an electric energy to be used when desired.
F01K 21/02 - Ensembles fonctionnels de machines motrices à vapeur non prévus ailleurs avec production de vapeur dans les cylindres des machines motrices
F01K 25/06 - Ensembles fonctionnels ou machines motrices caractérisés par l'emploi de fluides énergétiques particuliers non prévus ailleursEnsembles fonctionnant selon un cycle fermé, non prévus ailleurs utilisant un mélange de fluides différents
77.
TRANSLOCATOR PROTEIN LIGANDS AND INFLAMMATORY DISEASES
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israël)
Inventeur(s)
Gavish, Moshe
Abrégé
Methods for treating or reducing inflammation, in is in a site or an organ excluding the central nervous system of a subject in need thereof, by administering a pharmaceutical composition comprising the translocator protein ligand 2-C1-MGV-1, are provided.
A61K 31/517 - PyrimidinesPyrimidines hydrogénées, p. ex. triméthoprime condensées en ortho ou en péri avec des systèmes carbocycliques, p. ex. quinazoline, périmidine
C07D 239/91 - Atomes d'oxygène avec des radicaux aryle ou aralkyle liés en position 2 ou 3
A61P 1/00 - Médicaments pour le traitement des troubles du tractus alimentaire ou de l'appareil digestif
A61P 29/00 - Agents analgésiques, antipyrétiques ou anti-inflammatoires non centraux, p. ex. agents antirhumatismauxMédicaments anti-inflammatoires non stéroïdiens [AINS]
Technion Research & Development Foundation Limited (Israël)
Inventeur(s)
Pokroy, Boaz
Polishchuk, Iryna
Prudnikov, Elena
Segal, Ester
Abrégé
A process of depositing a hydrophobic or superhydrophobic film on a surface of a substrate, effected by spraying onto the substrate's surface a solution comprising a fatty acid and an organic solvent, is provided. Substrates and articles-of-manufacturing containing the substrates, having a hydrophobic or superhydrophobic coating/film deposited thereon, obtainable or prepared by the process, are also provided. The process is usable for reducing a load of a pathogenic microorganism and/or for preventing biofilm formation on and/or in the substrates or articles-of-manufacturing containing same.
B05D 5/08 - Procédés pour appliquer des liquides ou d'autres matériaux fluides aux surfaces pour obtenir des effets, finis ou des structures de surface particuliers pour obtenir une surface antifriction ou anti-adhésive
A23P 20/10 - Revêtement avec des produits de revêtement comestibles, p. ex. avec des huiles ou des graisses
B05D 1/02 - Procédés pour appliquer des liquides ou d'autres matériaux fluides aux surfaces réalisés par pulvérisation
C09D 5/14 - Peintures contenant des biocides, p. ex. fongicides, insecticides ou pesticides
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israël)
Inventeur(s)
Oryan (orian), Amir
Brik, Ashraf
Abu Ahmad, Yamen
Gandhesiri, Satish
Abrégé
The present invention provides compounds and pharmaceutical compositions comprising thereof. Further, methods for treating or preventing development of a RNF4 related disorder in a subject in need thereof are also provided.
C07D 417/12 - Composés hétérocycliques contenant plusieurs hétérocycles, au moins un cycle comportant des atomes de soufre et d'azote comme uniques hétéro-atomes du cycle, non prévus par le groupe contenant deux hétérocycles liés par une chaîne contenant des hétéro-atomes comme chaînons
Technion Research & Development Foundation Limited (Israël)
Inventeur(s)
Bronstein, Alexander
Weiss, Tomer
Peretz, Nissim
Vedula, Sanketh
Feuer, Arie
Abrégé
A method of designing a radar, comprises receiving data pertaining to a set of reflected signals received from a distribution of objects by a respective set of receiving antennas at a respective set of locations, and feeding the data and the locations as training data to a machine learning procedure. The machine learning procedure calculates, simultaneously, a set of learned antenna locations and a set of learned parameters associating the signals with the objects, thereby providing a trained machine learning procedure parametrized by the set of learned parameters.
G01S 7/41 - Détails des systèmes correspondant aux groupes , , de systèmes selon le groupe utilisant l'analyse du signal d'écho pour la caractérisation de la cibleSignature de cibleSurface équivalente de cible
Technion Research & Development Foundation Limited (Israël)
Inventeur(s)
Diesendruck, Charles Eliezer
Dekel, Dario R.
Abrégé
Polymeric ion conductors composed of a polymeric matrix associated with an isoindolinium moiety represented by Formula I as described in the specification are provided. Anion conducting compositions comprising an anion conducting polymer associated with, or threaded within and having mechanically interlocked therearound, a cyclic moiety are also provided. lonomeric materials, including, for example, ion exchange membranes such as anion exchange membranes, made of the polymeric ion conductor and/or the anion conducting composition, and electrochemical systems and articles-of-manufacturing containing the polymeric ion conductor, the anion conducting composition or the ion exchange membrane are also provided.
B01J 41/14 - Composés macromoléculaires obtenus par des réactions ne faisant intervenir que des liaisons carbone-carbone non saturées
B01J 41/05 - Procédés utilisant des échangeurs organiques sous forme fortement basique
B01J 47/12 - Procédés d'échange d'ions en généralAppareillage à cet effet caractérisés par l'emploi d'une substance échangeur d'ions sous forme de rubans, de filaments, de fibres ou de feuilles, p. ex. sous forme de membranes
H01M 8/103 - Matériaux d’électrolyte polymère caractérisés par la structure chimique de la chaîne principale du polymère conducteur ionique comprenant de l’azote, p. ex. des polybenzimidazoles sulfonés [S-PBI], des polybenzimidazoles comprenant de l’acide phosphorique, des polyamides sulfonés [S-PA] ou des polyphosphazènes sulfonés
Technion Research & Development Foundation Limited (Israël)
Inventeur(s)
Shechtman, Yoav
Opatovski, Nadav
Abrégé
In a range imaging system, a passive optical system has a set of lenses and an optical mask that varies a point spread function of the set of lenses so as to encode in an optical field arriving from a scene range information for objects in the scene that are at least X meters from the mask, where X is at least 10. A digital light sensor receives the optical field, and an image processor processes signals receive signals from the sensor to decode the range information.
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israël)
RAMBAM MED-TECH LTD. (Israël)
Inventeur(s)
Ciechanover, Aaron
Golts, Alona
Livneh, Ido
Zohar, Yaniv
Elad, Michael
Abrégé
The present disclosure is related to the field of machine learning (ML) based detection and classification. More specifically, the present disclosure provides computer implemented methods of detection and multi-class classification of objects of interest in an image, computer program product operable in a computer, and diagnostic methods thereof.
G06V 10/82 - Dispositions pour la reconnaissance ou la compréhension d’images ou de vidéos utilisant la reconnaissance de formes ou l’apprentissage automatique utilisant les réseaux neuronaux
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israël)
RAMBAM MED-TECH LTD. (Israël)
Inventeur(s)
Shen-Orr, Shai
Chowers, Yehuda
Gerassy-Vainberg, Shiran
Blatt, Alexandra
Starovetsky, Elina
Gaujoux, Renaud Gilles
Maimon, Naama
Abrégé
The present invention is directed to a kit and a method for determining the suitability of a subject to a treatment using a tumor necrosis factor alpha (TNFα). Further provided is a method for treating the subject determined to be suitable for a treatment using a TNFα inhibitor.
C12Q 1/6883 - Produits d’acides nucléiques utilisés dans l’analyse d’acides nucléiques, p. ex. amorces ou sondes pour les maladies provoquées par des altérations du matériel génétique
C07K 16/24 - Immunoglobulines, p. ex. anticorps monoclonaux ou polyclonaux contre du matériel provenant d'animaux ou d'humains contre des cytokines, des lymphokines ou des interférons
G01N 33/564 - Tests immunologiquesTests faisant intervenir la formation de liaisons biospécifiquesMatériaux à cet effet pour complexes immunologiques préexistants ou maladies auto-immunes
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israël)
Inventeur(s)
Samish, Ilan
Zuker, Inbar
Marko, Shmuel
Livney, Yoav
Goldman, Evgeniya
Edelman, Ravit
Pawar, Prerna Balkrishna
Alasibi, Samaa
Abrégé
The present invention relates to functional taste-improving composition comprising at least one taste-modifying protein (TMP), e.g., a sweet protein (SP) and at least one micropatching (MP) agent; and to uses thereof in the food and beverage industry.
A23L 27/00 - ÉpicesAgents aromatiques ou condimentsÉdulcorants artificielsSels de tableSubstituts diététiques du selLeur préparation ou leur traitement
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israël)
Inventeur(s)
Yelin, Dvir
Fridman, Lidan
Abrégé
A method of image enhancement of a reflectance confocal microscope is disclosed. The method comprises: receiving by a processor a first image captured by a detector of the confocal microscope, at a first position of a pinhole; receiving one or more second images captured by the detector, at at least one second position of the pinhole; and adding, by the processor, the one or more second images to the first image to reduce a speckle contrast in the combined image. In addition, the first position of the pinhole is a confocal position, and the at least one second position is a shifted position with respect to the confocal position.
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israël)
Inventeur(s)
Rotschild, Carmel
Cassell, Joseph
Neumann, Yuval
Abrégé
The present disclosure provides a novel configuration of a fluid pressurization nozzle which is relatively simple in its mechanical design for attaining an isothermal or quasi-isothermal pressurization process of fluid, e.g., isothermal or quasi-isothermal compression of gas. The fluid pressurization nozzle of the present disclosure utilizes the general principles of an expanding-contracting nozzle (e.g., Venturi nozzle), which is modified for eliminating or significantly attenuating generation of shock waves in the nozzle to thereby facilitate efficient compression of the gas. The fluid pressurization nozzle of the present disclosure has a profile defining a varying cross-section along a length thereof. As such, the fluid pressurization nozzle is configured for affecting / manipulating characteristics / properties of fluid(s) propagating therealong. Such properties can include, inter alia, pressure, Mach number, velocity, and temperature. Optionally, and in some embodiments preferably, the fluid compression nozzle of the present disclosure is configured to pressurize suction fluid (e.g., gas) introduced thereinto, with the aid of a heat transfer liquid (HTL) propagating / flowing therealong. The introduced suction fluid is mixed with the HTL to form a liquid/gas mixture in which the gas is pressurized.
F04F 5/04 - Pompes à jet, p. ex. dispositifs dans lesquels le flux est produit par la chute de pression causée par la vitesse d'un autre fluide le fluide inducteur étant un liquide déplaçant des fluides compressibles
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israël)
Health Corporation Of Tzafon Medical Center (R.A.) (Israël)
Inventeur(s)
Bianco-Peled, Havazelet
Schroeder, Avi
Abu El-Naaj, Imad
Habib, Layan
Alyan, Mohammed
Ghantous, Yasmin
Abrégé
A composition and method for the administration of therapeutic and/or diagnostic agents is provided. Specifically, a dry hybrid system, composed of bio adhesive polymer that harbors drug-loaded lipid nanoparticles, and use thereof for the administration of active agents e.g., anti-cancer agents or biological agents, is provided.
A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
A61K 9/127 - Vecteurs à bicouches synthétiques, p. ex. liposomes ou liposomes comportant du cholestérol en tant qu’unique agent tensioactif non phosphatidylique
89.
RECONSTRUCTION OF INFORMATION STORED IN A DNA STROAGE SYSTEM
Technion Research & Development Foundation Limited (Israël)
BAR-ILAN UNIVERSITY (Israël)
Inventeur(s)
Bar-Lev, Daniella
Orr, Itai
Sabary, Omer
Etzion, Tuvi
Yaakobi, Eitan
Abrégé
A method for estimating an information unit represented by DNA strands, the method includes (a) sequencing the DNA strands to provide noisy copies of an encoded version of the information unit; wherein the information unit comprises information unit elements; (b) neural network (NN) processing the multiple noisy copies by one or more NNs to provide a soft estimate of the encoded information unit; wherein the soft estimate comprises estimated encoded information unit elements and an encoded information unit elements estimated confidence parameter; and (c) decoding the soft estimate of the encoded information unit to provide a prediction of the information unit.
G06F 30/27 - Optimisation, vérification ou simulation de l’objet conçu utilisant l’apprentissage automatique, p. ex. l’intelligence artificielle, les réseaux neuronaux, les machines à support de vecteur [MSV] ou l’apprentissage d’un modèle
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israël)
RAMOT AT TEL-AVIV UNIVERSITY LTD. (Israël)
Inventeur(s)
Wolf, Alon
Gefen, Amit
Shaulian, Hadar
Abrégé
A foot support structure having: a foot support surface for engagement by a foot of a subject; and a tissue loading alleviation zone within the foot support surface, such that the tissue loading alleviation zone defines a region of the foot support surface configured for optimizing an internal tissue loading state in a volume-of-interest (VOI) in said foot of said subject, and the region has at least one mechanical property value that gradually varies along at least one dimension of the region.
A43B 7/1455 - Chaussures avec dispositions médicales ou hygiéniques avec éléments pour soutenir le pied munies de coussinets ou de trous à un ou plusieurs endroits, ou ayant une forme anatomique ou courbe avec des propriétés particulières
A43B 7/144 - Chaussures avec dispositions médicales ou hygiéniques avec éléments pour soutenir le pied munies de coussinets ou de trous à un ou plusieurs endroits, ou ayant une forme anatomique ou courbe caractérisés par leur emplacement sous le pied situés sous le talon, c.-à-d. sous le calcanéus
A61B 5/103 - Dispositifs de mesure pour le contrôle de la forme, du dessin, de la dimension ou du mouvement du corps ou de parties de celui-ci, à des fins de diagnostic
91.
RNAI NANOPARTICLES AND METHODS OF USING SAME IN AGRICULTURE
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (Israël)
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israël)
Inventeur(s)
Shoseyov, Oded
Schroeder, Avi
Avital, Aviram
Sadot Muzika, Noy
Persky, Zohar Lily
Abrégé
The present invention provides a nanoparticle including: (a) an amphiphilic co-polymer including an ionizable polymer covalently bound to a hydrophobic domain; and a polynucleotide comprising 60 to 500 nucleobases. Further provided are compositions including the nanoparticle of the invention, and methods of using same.
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LTD (Israël)
Inventeur(s)
Gross, Zeev
Mahammed, Atif
Abrégé
Embodiments of the invention relate to a corrole according to formula [I]; wherein R1, R2, and R3 are each independently H, —COOH, CF3, or a halide selected from the group consisting of F—, Cl—, Br— and I, with the proviso that R1, R2, and R3 can not all be CF3, and when the compound is of Formula II, wherein M is a metallic ion or an elemental ion selected from the group consisting of an elemental ion of group 13-16 in row 3 or above and boron, preferably selected from the group consisting of: Fe, Mn, Ga, P, Mo, Re, Co and Cu, or a salt thereof. Methods for treatment, catalysis, and detection using the compounds are also described.
C07F 5/00 - Composés contenant des éléments des groupes 3 ou 13 du tableau périodique
B01J 31/18 - Catalyseurs contenant des hydrures, des complexes de coordination ou des composés organiques contenant des complexes de coordination contenant de l'azote, du phosphore, de l'arsenic ou de l'antimoine
B01J 35/00 - Catalyseurs caractérisés par leur forme ou leurs propriétés physiques, en général
C07D 487/22 - Composés hétérocycliques contenant des atomes d'azote comme uniques hétéro-atomes dans le système condensé, non prévus par les groupes dans lesquels le système condensé contient au moins quatre hétérocycles
C07F 13/00 - Composés contenant des éléments des groupes 7 ou 17 du tableau périodique
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israël)
Inventeur(s)
Shamay, Yosi
Harris, Yuval
Niezni, Danna
Sason, Hagit
Abrégé
The present invention relates to a composition comprising a mixture of oligomers or co-oligomers obtained by exposing an indolium-based monomer, optionally together with an additional monomer selected from dopamine, L-dopa, norepinephrine, serotonin, and a mixture thereof, to a basic buffer. The composition disclosed may further comprise a hydrophobic substance such as a drug or dietary supplement, stabilized by said oligomers above.
A61K 31/4045 - Indole-alkylaminesLeurs amides, p. ex. sérotonine, mélatonine
A61K 31/14 - Composés d'ammonium quaternaire, p. ex. édrophonium, choline
A61K 35/02 - Préparations médicinales contenant des substances ou leurs produits de réaction de constitution non déterminée à partir de substances inanimées
A61K 9/14 - Préparations médicinales caractérisées par un aspect particulier à l'état particulaire, p. ex. poudres
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israël)
Inventeur(s)
Blanc, Nathan
Ramon, Guy
Agnon, Yehuda
Meir, Avishai
Abrégé
A thermoacoustic engine that consists essentially of: a heat exchanger; and a resonator that is in communication with the heat exchanger. The resonator includes a media configured to absorb one or more electromagnetic signals. The thermoacoustic engine is configured to receive the one or more electromagnetic signals and generate acoustic power.
Technion Research & Development Foundation Limited (Israël)
Inventeur(s)
Diesendruck, Charles Eliezer
Dekel, Dario R.
Abrégé
Polymeric ion conductors composed of a polymeric or co-polymeric backbone which comprises a plurality of backbone units, a metal ligand attached to at least a portion of the backbone units, and a metal ion attached to the metal ligand are provided. The metal ligand can be an N-heterocyclic carbene ligand and the metal can feature low oxophilicity. lonomeric materials, including, for example, ion exchange membranes such as anion exchange membranes, made of the polymeric ion conductor, and electrochemical systems and articles-of-manufacturing containing the polymeric ion conductor or the ion exchange membrane are also provided.
H01M 8/1023 - Matériaux d’électrolyte polymère caractérisés par la structure chimique de la chaîne principale du polymère conducteur ionique comprenant uniquement du carbone, p. ex. des polyarylènes, des polystyrènes ou des polybutadiène-styrènes
H01M 8/1067 - Matériaux d’électrolyte polymère caractérisés par leurs propriétés physiques, p. ex. la porosité, la conductivité ionique ou l’épaisseur
96.
AURICULAR RECONSTRUCTION USING 3D PRINTED AUTOLOGOUS CARTILAGE TISSUE
Technion Research & Development Foundation Limited (Israël)
Tel HaShomer Medical Research Infrastructure and Services Ltd. (Israël)
Inventeur(s)
Levenberg, Shulamit
Landau, Shira
Duvdevani, Shay
Abrégé
An aspect of some embodiments of the invention relates to methods of manufacturing a 3D printed implant, comprising printing a mold of a scaffold, generating said scaffold from said mold, seeding cells on said scaffold, where said generating said scaffold comprises generating parts of said scaffold with different levels of stiffness.
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israël)
Inventeur(s)
Meiri, David
Wyrobnik, Iris
Novak Kotzer, Hila
Steinberg, Miryam
Gelfand, Anat
Procaccia, Shiri
Abrégé
The present invention provides a pharmaceutical composition including cannabigerol, and methods of using same, such as for increasing therapeutic efficacy of an immune checkpoint inhibitor, or for the treatment of cancer.
Technion Research & Development Foundation Limited (Israël)
Inventeur(s)
Freiman, Mordechay Pinchas
Avidan, Nitzan
Abrégé
A method for reconstructing spatial information, the method includes: (i) Obtaining an under-sampled frequency domain representation (FDR) of the spatial information. The under-sampled FDR was obtained by sampling an FDR of the spatial information with a sampling mask. (ii) Feeding the under-sampled FDR and the sampling mask to a machine learning process. (iii) Reconstructing the spatial information by the machine learning process. The machine learning process was trained using a training data set that includes training under-sampled FRDs of training spatial information, and one or more training sampling masks that were used to sample FDRs of training spatial information.
A61B 5/055 - Détection, mesure ou enregistrement pour établir un diagnostic au moyen de courants électriques ou de champs magnétiquesMesure utilisant des micro-ondes ou des ondes radio faisant intervenir la résonance magnétique nucléaire [RMN] ou électronique [RME], p. ex. formation d'images par résonance magnétique
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israël)
Inventeur(s)
Meir, Avishai
Agnon, Yehuda
Ramon, Guy
Blanc, Nathan
Cassell, Joseph
Abrégé
A pump system wherein a pressure storage unit configured to receive input pressure for build-up of pressurized gaseous material thereinside and communicate the same to a pumping unit at least partially submerged in a body-of-liquid. The pumping unit comprises an internal liquid passage extending upwardly a certain length from a bottom opening thereof, a discharge tube at least partially accommodating by a bottom end potion thereof a portion of the internal liquid passage, a gas -liquid vessel in fluid communication with the discharge tube and configured to receive via an upper portion thereof pressurized gaseous material from the pressure storage unit, to thereby lift a certain amount of liquid towards a liquid outlet of the discharge tube.
E21B 43/12 - Procédés ou appareils pour commander l'écoulement du fluide extrait vers ou dans les puits
F04B 47/08 - Pompes ou installations de pompage spécialement adaptées pour élever un fluide à partir d'une grande profondeur, p. ex. pompes de puits dont les ensembles pompe-moteur sont placés à grande profondeur les moteurs étant actionnés par un fluide
F04F 1/08 - Pompes utilisant un fluide intermédiaire, en surpression ou en sous-pression, agissant directement sur le liquide à pomper le fluide intermédiaire agissant sur la surface du liquide à pomper et spécialement adaptées pour élever le liquide à partir d'une grande profondeur, p. ex. dans un puits
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israël)
Inventeur(s)
Hasson, Peleg
Wolfenson, Haguy
Melamed, Shay
Eilot, Shelly
Boger, Elisabeth
Aviram, Rohtem
Abrégé
An isolated peptide comprising an amino acid sequence of a lysyl oxidase (LOX) family member target site of an extracellular matrix protein, the peptide being no longer than 50 amino acids, for use in treating a disease associated with fibrosis in a subject in need thereof.
C07K 14/78 - Peptides du tissu connectif, p. ex. collagène, élastine, laminine, fibronectine, vitronectine ou globuline insoluble à froid [CIG]
A61K 38/39 - Peptides du tissu connectif, p. ex. collagène, élastine, laminine, fibronectine, vitronectine, globuline insoluble à froid [CIG]
A61K 47/68 - Préparations médicinales caractérisées par les ingrédients non actifs utilisés, p. ex. les supports ou les additifs inertesAgents de ciblage ou de modification chimiquement liés à l’ingrédient actif l’ingrédient non actif étant chimiquement lié à l’ingrédient actif, p. ex. conjugués polymère-médicament l’ingrédient non actif étant un agent de modification l’agent de modification étant un anticorps, une immunoglobuline ou son fragment, p. ex. un fragment Fc
A61P 43/00 - Médicaments pour des utilisations spécifiques, non prévus dans les groupes